approval
saveLISDEXAMFETAMINE DIMESYLATE — FDA approval
community read0 votes
Sponsor: ASCENT PHARMS INC. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
- approvalARYNTA (LISDEXAMFETAMINE DIMESYLATE) — FDA approvalDec 22, 2025 · 288d ago
- approvalARYNTA (LISDEXAMFETAMINE DIMESYLATE) — FDA approvalJun 16, 2025 · 477d ago
- approvalLISDEXAMFETAMINE DIMESYLATE — FDA approvalJan 23, 2025 · 621d ago
- approvalLISDEXAMFETAMINE DIMESYLATE — FDA approvalAug 25, 2023 · 1138d ago
same company · ±60 days · 3
- approvalGUANFACINE HYDROCHLORIDE: GUANFACINE HYDROCHLORIDE — FDA approvalMar 24, 2026
- approvalnavepegritide: YUVIWEL (NAVEPEGRITIDE) — FDA approvalFeb 27, 2026
- approvalBUPRENORPHINE HYDROCHLORIDE: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalJan 21, 2026
🐶 often sniffed alongside
top 8- tagApproval112 co-mentions · 56 sources
- drugARYNTA97 co-mentions · 74 sources
- tagSmall Molecule56 co-mentions · 56 sources
- companySun Pharmaceutical Industries Ltd31 co-mentions · 10 sources
- tagRecall17 co-mentions · 10 sources
- companyOhm Laboratories Inc15 co-mentions · 8 sources
- tagDrug Shortage8 co-mentions · 8 sources
- companyApotex Corp1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that